A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects

Articles > Abstract · 2017

Authors: Ahmet Gül, Sibel Ulker, Recep Selim Senturk, Ugur Onsel Turk, Cemil GÜRGÜN, Yan Lavrovsky, Mikhail Samsonov, Sebnem Ozen, Serdar Altinel

ARTHRITIS & RHEUMATOLOGY, Journal Indexed in SCI Expanded, International, 2017, vol 69

View details